[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334992-105":59,"doc-detail-334992-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cellular-senescence-in-metastatic-prostate-cancer-a-therapeutic-opportunity-or-challenge-review","Cellular senescence in metastatic prostate cancer - A therapeutic opportunity or challenge - Review","","Metastatic prostate cancer treatment remains a persistent challenge, and conventional therapies can induce cellular senescence in cancer cells. Although senescent cells may restrain proliferation and enhance immune clearance, the senescent microenvironment can drive a senescence-associated secretory phenotype that weakens immune function and supports recurrence and metastasis. Drug resistance to established regimens is a major barrier to durable control. This review analyzes treatment-induced senescence, its dual roles, and underlying molecular mechanisms, and outlines therapeutic strategies targeting these processes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cellular-senescence-in-metastatic-prostate-cancer-a-therapeutic-opportunity-or-challenge-review/334992/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cellular-senescence-in-metastatic-prostate-cancer-a-therapeutic-opportunity-or-challenge-review/334992.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why does treatment-induced senescence complicate metastatic prostate cancer therapy?","Question",{"text":113,"@type":114},"Therapy-induced senescence can slow cell proliferation and help immune clearance, but it also produces a senescence-associated secretory phenotype that can impair immune function and promote tumor recurrence and metastasis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does the senescence-associated secretory phenotype (SaSP) play in metastasis?",{"text":118,"@type":114},"SaSP includes cytokines, chemokines, inflammatory factors, and proteases, which can promote epithelial-mesenchymal transition and angiogenesis—processes central to metastatic spread.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the major obstacle in treating metastatic prostate cancer described in the review?",{"text":122,"@type":114},"Resistance to established therapies, which can lead disease progression toward an incurable state, is emphasized as the primary challenge.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334992,1790195702,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Molecular Medicine rePorTS 30: 162, 2024  \nCellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge (Review)  \ncen Jin 1,2* , SiJian liao3* , GuolianG lu4 , Bill d. GenG5 , Zi Ye3 , JianWei Xu 1 , Guo Ge6 and dan YanG7  \n1center for Tissue engineering and Stem cell research, Guizhou Medical university, Guiyang, Guizhou 561113, P.r. china;  \n2Medical imaging School, Guizhou Medical university, Guiyang, Guizhou 561113, P.r. china; 3clinical Medicine School,  \n4  \nGuizhou Medical university, Guiyang, Guizhou 561113, P.r. china; department of Pediatrics, anshun People's Hospital, anshun, Guizhou 561000, P.r. china; 5School of natural Science, university of Texas at austin, austin, TX 78712, uSa;  \n6  \ndepartment of Human anatomy, School of Basic Medicine, Guizhou Medical university, Guiyang, Guizhou 561113, P.r. china; 7department of Surgery, clinical Medical college, Guizhou Medical university, Guiyang, Guizhou 561113, P.r. china  \nreceived March 7, 2024; accepted June 14, 2024  \ndoi: 10. 3892/mmr.2024.13286  \nAbstract. The treatment of patients with metastatic prostate cancer (Pca) is considered to be a long‑standing challenge. conventional treatments for metastatic Pca, such as radical prostatectomy, radiotherapy and androgen receptor‑targeted therapy, induce senescence of Pca cells to a certain extent. While senescent cells can impede tumor growth through the restriction of cell proliferation and increasing immune clearance, the senescent microenvironment may concurrently stimulate the secretion of a senescence‑associated secre‑ tory phenotype and diminish immune cell function, which promotes Pca recurrence and metastasis. resistance to estab‑ lished therapies is the primary obstacle in treating metastatic Pca as it can lead to progression towards an incurable state of disease. Therefore, understanding the molecular mechanisms that underly the progression of Pca is crucial for the devel‑ opment of novel therapeutic approaches. The present study reviews the phenomenon of treatment‑induced senescence in Pca, the dual role of senescence in Pca treatments and the mechanisms through which senescence promotes Pca metas‑ tasis . Furthermore, the present review discusses potential therapeutic strategies to target the aforementioned processes  \nCorrespondence to: dr Guo Ge, department of Human anatomy, School of Basic Medicine, Guizhou Medical university, 6 ankang road, Guiyang, Guizhou 561113, P.r. china  \ne‑mail: [guoge113@163.com](guoge113@163.com)  \ndr dan Yang, department of Surgery, clinical Medical college, Guizhou Medical university, 6 ankang road, Guiyang, Guizhou 561113, P.r. china  \ne‑mail: [398207169@qq.com](398207169@qq.com)  \n*contributed equally  \nKey words: prostate cancer, metastasis, senescence, secretome, therapy  \nwith the aim of providing insights into the evolving therapeutic landscape for the treatment of metastatic Pca.  \nContents  \n1. introduction  \n2. cellular senescence  \n3. The SaSP  \n4. association between senescence and Pca  \n5. Therapeutic approaches and future outlook  \n6. Summary  \n1. Introduction  \nProstate cancer (Pca) is a type of malignant tumor that origi‑ nates in the epithelium of the prostate gland. according to the 2023 american cancer Society report, Pca is ranked as the second most common type of cancer in men worldwide and is a leading cause of cancer‑related death in the male popu‑ lation (1,2) . although radical prostatectomy is an effective strategy in treating early‑stage Pca, a number of patients with Pca present with distant metastases at diagnosis (3) . Surgical removal of the tumor, or chemical and surgical castration, are the standard treatments for patients with advanced Pca . However, a large proportion of patients with Pca that are initially responsive to endocrine therapy progress to chemore‑ sistant Pca (crPc) in 18‑24 months (4) . Patients with crPc typically develop metastases; bone and lymph node metastases are the most common types of metast","cbCaikCC81etO1mu","https://ap.wps.com/l/cbCaikCC81etO1mu","pdf",2207868,13,"English","# Introduction\n# Cellular senescence\n## The SaSP\n# Association between senescence and Pca\n# Therapeutic approaches and future outlook\n# Summary","[{\"question\":\"Why does treatment-induced senescence complicate metastatic prostate cancer therapy?\",\"answer\":\"Therapy-induced senescence can slow cell proliferation and help immune clearance, but it also produces a senescence-associated secretory phenotype that can impair immune function and promote tumor recurrence and metastasis.\"},{\"question\":\"What role does the senescence-associated secretory phenotype (SaSP) play in metastasis?\",\"answer\":\"SaSP includes cytokines, chemokines, inflammatory factors, and proteases, which can promote epithelial-mesenchymal transition and angiogenesis—processes central to metastatic spread.\"},{\"question\":\"What is the major obstacle in treating metastatic prostate cancer described in the review?\",\"answer\":\"Resistance to established therapies, which can lead disease progression toward an incurable state, is emphasized as the primary challenge.\"}]","Cellular senescence in metastatic prostate cancer - A therapeutic opportunity or challenge - Review | PDF",1790009159,33]